BioLife Solutions Inc (BLFS)

Currency in USD
21.09
+0.36(+1.74%)
Closed·
After Hours
21.090.00(0.00%)
·
BLFS Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
Earnings results expected today
BLFS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.2321.31
52 wk Range
19.1029.55
Key Statistics
Prev. Close
21.09
Open
20.62
Day's Range
20.23-21.31
52 wk Range
19.1-29.55
Volume
618.86K
Average Volume (3m)
543.96K
1-Year Change
-7.82%
Book Value / Share
7.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLFS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
31.10
Upside
+47.46%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

BioLife Solutions Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

BioLife Solutions Inc Company Profile

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

BioLife Solutions Inc Earnings Call Summary for Q1/2025

  • BioLife Solutions beats Q1 2025 expectations with EPS of -$0.01 vs -$0.05 forecast; revenue reaches $23.9M, up 30% YoY
  • Stock rises 4.73% post-earnings; analysts maintain strong buy consensus with price targets of $30-$34
  • Cell processing platform revenue grows 33%; adjusted EBITDA margin improves to 24%
  • Full-year revenue guidance of $95.5M-$99M, representing 16-20% growth; no substantial revenue expected from Panthera acquisition in 2025
  • CEO highlights solid top-line performance and strong footing in dynamic operating environment
Last Updated: 08/05/2025, 22:16
Read Full Transcript

Compare BLFS to Peers and Sector

Metrics to compare
BLFS
Peers
Sector
Relationship
P/E Ratio
−116.8x−4.6x−0.5x
PEG Ratio
−1.38−0.080.00
Price/Book
2.9x1.3x2.6x
Price / LTM Sales
11.5x2.1x3.3x
Upside (Analyst Target)
44.6%69.3%43.5%
Fair Value Upside
Unlock24.5%6.9%Unlock

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 31.10
(+47.46% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.01 / -0.05
Revenue / Forecast
23.94M / 22.17M
EPS Revisions
Last 90 days

BLFS Income Statement

People Also Watch

54.62
NXT
-2.50%
37.71
EXEL
+0.67%
196.11
DAVE
-17.89%
430.37
MEDP
-1.36%
90.01
RYTM
+1.63%

FAQ

What Stock Exchange Does BioLife Solutions Trade On?

BioLife Solutions is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for BioLife Solutions?

The stock symbol for BioLife Solutions is "BLFS."

What Is the BioLife Solutions Market Cap?

As of today, BioLife Solutions market cap is 1.01B.

What Is BioLife Solutions's Earnings Per Share (TTM)?

The BioLife Solutions EPS (TTM) is -0.19.

When Is the Next BioLife Solutions Earnings Date?

BioLife Solutions will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is BLFS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioLife Solutions Stock Split?

BioLife Solutions has split 2 times.

How Many Employees Does BioLife Solutions Have?

BioLife Solutions has 159 employees.

What is the current trading status of BioLife Solutions (BLFS)?

As of 07 Aug 2025, BioLife Solutions (BLFS) is trading at a price of 21.09, with a previous close of 21.09. The stock has fluctuated within a day range of 20.23 to 21.31, while its 52-week range spans from 19.10 to 29.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.